BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2
52321 results:

  • 1. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.
    Li X; Wu D; Tang J; Wu Y
    J Cancer Res Clin Oncol; 2024 May; 150(5):271. PubMed ID: 38780840
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical pharmacokinetics and pharmacodynamics of venetoclax, a selective B-cell lymphoma-2 inhibitor.
    Salem AH; Menon RM
    Clin Transl Sci; 2024 May; 17(5):e13807. PubMed ID: 38778732
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of the prevalence of Aeromonas spp., Campylobacter spp., and Clostridioides difficile in immunocompromised children with diarrhea.
    Heydari H; Iranikhah A; Ghasemi A; Mohammadbeigi A; Sadat-Mirei SA; Shams S; Kermani S
    BMC Infect Dis; 2024 May; 24(1):512. PubMed ID: 38778271
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL.
    Wang X; Deng Y; He G; Lai S; Li Y; Zhang S; He Y; Han Y; Zhang L; Su Y; Liu F; Yi H
    Hematology; 2024 Dec; 29(1):2356300. PubMed ID: 38776229
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
    Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
    Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length.
    Carlund O; Thörn E; Osterman P; Fors M; Dernstedt A; Forsell MNE; Erlanson M; Landfors M; Degerman S; Hultdin M
    Clin Epigenetics; 2024 May; 16(1):68. PubMed ID: 38773655
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
    Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
    Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival.
    Li T; Liu J; Zhou Y; Huang S; Wang D; Chen J; Fu Y; He P
    Cancer Med; 2024 May; 13(10):e7227. PubMed ID: 38770632
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Proteomic characterization and cytotoxic potential of proteins from Cuscuta (Cuscuta epithymum (L.) crude herbal product against MCF-7 human breast cancer cell line.
    Akhtar U; Khurshid Y; El-Aarag B; Syed B; Khan IA; Parang K; Ahmed A
    BMC Complement Med Ther; 2024 May; 24(1):195. PubMed ID: 38769554
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Arsenic disulfide promoted the demethylation of
    Chen C; Wang L; Liu Y; Du S; Teng Q
    PeerJ; 2024; 12():e17363. PubMed ID: 38766487
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
    Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
    Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
    Pasvolsky O; Wang Z; Milton DR; Tanner MR; Bashir Q; Srour S; Saini N; Lin P; Ramdial J; Nieto Y; Tang G; Kebriaei P; Aljawai Y; Khan HN; Lee HC; Ye C; Patel KK; Thomas SK; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH
    Blood Cancer J; 2024 May; 14(1):82. PubMed ID: 38760362
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy.
    Kwak K; Park Y; Kim BS; Kang KW
    Sci Rep; 2024 May; 14(1):11229. PubMed ID: 38755279
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.
    Gao Y; He H; Li X; Zhang L; Xu W; Feng R; Li W; Xiao Y; Liu X; Chen Y; Wang X; Bai B; Wu H; Cai Q; Li Z; Li J; Lin S; He Y; Ping L; Huang C; Mao J; Chen X; Zhao B; Huang H
    Signal Transduct Target Ther; 2024 May; 9(1):121. PubMed ID: 38755119
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Evaluation of sex inequity in lung-cancer-specific survival.
    Lærum D; Strand TE; Brustugun OT; Gallefoss F; Falk R; Durheim MT; Fjellbirkeland L
    Acta Oncol; 2024 May; 63():343-350. PubMed ID: 38751329
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysis.
    Brazel D; Grant C; Cabal A; Chen WP; Pinter-Brown L
    Front Immunol; 2024; 15():1334899. PubMed ID: 38745669
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
    Hou PX; Fan Q; Zhang Q; Liu JJ; Wu Q
    Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13868. PubMed ID: 38745265
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Analysis on the ultrasonic characteristics of tonsillar lymphoma].
    Yue B; Zhu JL; Shi CL; Wang M; Wei X
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):457-460. PubMed ID: 38742359
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 2617.